BMJ Case Reports 2014; doi:10.1136/bcr-2013-203180

Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma

  1. Gunver Sophia Kienle1
  1. 1Institute for Applied Epistemology and Medical Methodology at the University of Witten/Herdecke, Freiburg, Germany
  2. 2Medical Practice for General Medicine, Koblenz, Germany
  3. 3Faculty of Health, Chair of Theory of Medicine, Integrative and Anthroposophic Medicine, Institute of Integrative Medicine, University of Witten/Herdecke, Herdecke, Germany
  1. Correspondence to Paul Georg Werthmann, paul.werthmann{at}
  • Accepted 14 July 2014
  • Published 31 July 2014


Adenoid cystic carcinoma (ACC) is a rare type of cancer that typically originates in the salivary glands. Surgical removal can lead to functional loss and psychological distress. Viscum album extract (VAE) is a herbal remedy with dose-dependent cytotoxic, apoptogenic and immunological effects. In some case reports, tumour regression has been observed following high-dose local applications of VAE. An active 88-year-old man with fast-growing ACC of the hard palate refused surgical removal and received high-dose intratumoural injections of VAE (alone) over a 10-month period. The tumour decreased in size, softened and loosened from its surroundings. A biopsy during the course showed inflammation. The patient remained well and without functional limitations during the therapy and follow-up period (5 months). VAE produced no reported side effects. This aged patient exemplifies a satisfying course of ACC under VAE resulting in good quality of life and partial tumour regression.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article